Today: 12 May 2026
Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade
5 January 2026
1 min read

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

New York, Jan 5, 2026, 15:24 EST

  • U.S. blue chips are leaning on share buybacks to lift per-share metrics as 2026 gets underway.
  • GM, Southwest and Tapestry were flagged for double-digit buyback yields after heavy 2025 repurchases.
  • Investors are watching whether companies can keep repurchasing without squeezing investment or balance sheets.

General Motors, Southwest Airlines and Tapestry ended 2025 with last-12-month buyback yields above 10% after repurchasing stock worth $8.2 billion, $2.75 billion and $2.8 billion, respectively, MarketBeat wrote on Monday. GM shares rose nearly 53% in 2025, while Southwest gained 23% and Tapestry climbed 96%, the report said.

The renewed focus on buybacks comes as investors look for durable supports for equity returns at the start of a new year. Repurchases reduce the number of shares outstanding, which can lift earnings per share even when a company’s overall profit growth slows.

That matters because the market’s appetite for “per-share” improvement has broadened beyond the usual tech giants. In sectors where sales growth is patchy, buybacks can still bolster per-share metrics — and, in turn, valuations — if cash flow holds up.

Buyback yield is one shorthand investors use to compare repurchase intensity across companies of different sizes. It measures net buybacks — repurchases minus share issuance — as a percentage of a firm’s market value, offering a quick read on how fast a company is shrinking its share count.

MarketMinute said aggressive buybacks have become a central tool for companies trying to steady stock prices during uncertainty and signal confidence, even as investors debate whether repurchases are replacing spending on longer-term growth. The outlet pointed to big tech names such as Apple, Alphabet and Meta Platforms as leaders in total buyback dollars, while highlighting higher-yield repurchasers in other sectors.

S&P Dow Jones Indices said S&P 500 companies bought back $249.0 billion of stock in the third quarter of 2025, and repurchases totaled a record $1.020 trillion over the 12 months through September 2025. “The 1% tax continues to be a manageable expense and has not impacted overall buybacks,” Howard Silverblatt, senior index analyst at S&P Dow Jones Indices, said in a December update on repurchase trends. News Release Archive

The mechanics can create a gap between a company’s market capitalization and its stock’s performance. If the share count falls fast enough, the price per share can rise even when the company’s total value barely moves.

Still, buybacks are not a free lunch. Repurchases funded with heavier borrowing can raise risk if interest rates rise, and investors can sour quickly if buybacks appear to crowd out spending on factories, technology, or other investment that keeps a business competitive.

For 2026, portfolio managers are likely to track repurchase pace alongside cash flow, leverage and dilution from stock-based compensation. A high buyback yield can signal confidence — or a lack of better places to deploy capital — and the difference often shows up in operating results a few quarters later.

Stock Market Today

  • IRSA Removes Warrants from NYSE Listing
    May 12, 2026, 10:59 AM EDT. IRSA Investments & Representations Inc has filed a Form 25 to remove its warrants to purchase common shares from the New York Stock Exchange (NYSE). The filing follows Section 12(b) of the Securities Exchange Act of 1934, which governs the removal of securities from listing. The NYSE certified its compliance with the requirements for this delisting. This move affects IRSA's warrants traded on the NYSE, marking a significant change for investors holding these securities. The notification was signed off by Tyler Mastronardi, Market Watch Analyst, on May 12, 2026.

Latest article

The AI Memory ETF That Beat Bitcoin Mania Just Hit $6.5 Billion in 36 Days

The AI Memory ETF That Beat Bitcoin Mania Just Hit $6.5 Billion in 36 Days

12 May 2026
Roundhill Investments’ Memory ETF, trading as DRAM, has reached $6.5 billion in assets just 36 days after launch, fueled by investor demand for AI memory chip exposure. The fund, recently down 4.8% at $52.44, is heavily weighted toward Samsung, SK Hynix, and Micron. A leveraged version has been filed with the SEC. DRAM has drawn over $150 million in retail net buying this month, outpacing flows into Nvidia and Micron.
Intel Stock Pulls Back as AI Foundry Rally Meets Valuation and CPI Pressure

Intel Stock Pulls Back as AI Foundry Rally Meets Valuation and CPI Pressure

12 May 2026
Intel shares fell 2.8% to $125.84 Tuesday morning after a sharp rally fueled by reports of advanced-packaging work with SK hynix and speculation about new foundry customers. The drop followed gains driven by optimism over AI server demand and a possible chipmaking deal with Apple. Intel recently reported Q1 revenue of $13.6 billion, up 7% year-over-year, and forecast Q2 revenue of $13.8–$14.8 billion.
Nvidia’s Record Run Is Now a Test of How Much AI Spending the Market Still Trusts

Nvidia’s Record Run Is Now a Test of How Much AI Spending the Market Still Trusts

12 May 2026
Nvidia shares climbed 1.2% to near $222 after a record close, as investors positioned ahead of May 20 earnings and focused on strong AI hardware demand from hyperscalers. CEO Jensen Huang was excluded from Trump’s China delegation, highlighting ongoing export risks, but the company’s outlook already assumes no China data center revenue. Nvidia guided first-quarter fiscal 2027 revenue to $78 billion, plus or minus 2%.
Palo Alto Networks stock climbs after report flags $400 mln Koi Security talks, analysts turn less bearish
Previous Story

Palo Alto Networks stock climbs after report flags $400 mln Koi Security talks, analysts turn less bearish

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms
Next Story

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Go toTop